WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1'0401 Infant (under 12 months) mortality rate: 472
GDP / capita (US$): 1'9441 Child (under 5 years) mortality rate: 652

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 13'726  13'331  12'951  12'587  12'239  9'862  7'514  5'569 
Births 524  513  502  489  477  396  328  271 
Surviving infants 498  487  476  464  451  370  304  246 
Pop. less than 5 years 2'313  2'249  2'189  2'130  2'078  1'684  1'388  1'087 
Pop. less than 15 years 5'977  5'809  5'651  5'500  5'360  4'449  3'540  2'601 
Female 15-49 years 3'343  3'248  3'154  3'061  2'970  2'299  1'626  1'199 

Number of reported case

(Click for retrospective incidence data for Senegal)
Diphtheria 291 
Japanese encephalitis
Measles 46  18  428  999  5'839  5'004  29'144 
Mumps
Pertussis 45  1'041  22'792 
Polio* 18  138 
Rubella 44  141  50  55  161 
Rubella (CRS)
Tetanus (neonatal) 14  21  12  16  16  67 
Tetanus (total) 118  144  21  16  252  109  1'378 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Senegal)
Vaccine year result method % card seen                                                
BCG 2011  97  EPI   81.1  94  95  80  97  98  89  90 
DTP1 2011  97  EPI   81.1  94  80  94  94  79 
DTP3 2011  92  EPI   81.1  83  83  70  86  88  52  66 
HepB_BD          81 
HepB3 2011  92  EPI   81.1  83  83  70  86  88 
Hib3 2011  92  EPI   81.1  83  83  70  86  88 
JapEnc         
MCV 2011  84  EPI   81.1  82  82  60  79  77  48  57 
MCV2         
PCV1         
PCV3         
Pol3 2011  89  EPI   81.1  73  73  70  83  87  49  66 
Rota1         
Rota_last         
Rubella1         
TT2plus 2009  57  DHS   66.4  70  60  78  81  45  37 
PAB         
VAD1          60  60  99  96 
YFV 2011  84  EPI   81.1  82  81  60  71  77  34 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Senegal)
BCG 97  97  97  97  98  89  90 
DTP1 97  97  96  94  94  79  75 
DTP3 92  92  89  86  88  52  51 
HepB3 92  92  89  86  88 
Hib3 92  92  89  86  88 
MCV 84  84  82  79  77  48  51 
PAB 91  88  88  88  88  62  45 
PCV3
Pol3 89  89  79  83  87  49  53 
Rota_last
YFV 84  84  82  80  84  34 

Number of districts in the country 76  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHep 6, 10, 14 weeks; Yes
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
TT x2 doses; Yes Pregnant women
VitaminA 6-11, 12-59 months; Yes and lacting women
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2013-2017  2012-2016  2007-2011  2007 - 2011  2007 - 2011  2007 - 2011   
Nº of districts with microplans that include activities to raise immunization coverage number 76  75  65  65  65  63  56 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number 76  75  65  65  65  63  56 
Nº districts with DTP3 coverage >=80% number     46  44  58  44 
% of districts with DTP3 coverage >=80% From 0 to 100%     71  68  92  79 
Nº districts with measles (MCV1) coverage >=95% number        
% of districts with MCV1 coverage >=95% From 0 to 100%        

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 27  32  100  17  100  31  37 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  No  No  No  No  No 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.